These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6643413)

  • 1. Behavior and anxiety: physiologic mechanisms.
    Lader M
    J Clin Psychiatry; 1983 Nov; 44(11 Pt 2):5-11. PubMed ID: 6643413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neuropsychology of anxiety: reprise.
    Gray JA; McNaughton N
    Nebr Symp Motiv; 1996; 43():61-134. PubMed ID: 8912308
    [No Abstract]   [Full Text] [Related]  

  • 3. [Proposal of an integrated model of normal and abnormal behavior based on biochemical, neurophysiological, ethological, clinical and sociological data].
    Laborit H
    Ann Med Psychol (Paris); 1974 Jan; 1(1):47-60. PubMed ID: 4845409
    [No Abstract]   [Full Text] [Related]  

  • 4. Transgenic mice overexpressing the full-length neurotrophin receptor TrkC exhibit increased catecholaminergic neuron density in specific brain areas and increased anxiety-like behavior and panic reaction.
    Dierssen M; Gratacòs M; Sahún I; Martín M; Gallego X; Amador-Arjona A; Martínez de Lagrán M; Murtra P; Martí E; Pujana MA; Ferrer I; Dalfó E; Martínez-Cué C; Flórez J; Torres-Peraza JF; Alberch J; Maldonado R; Fillat C; Estivill X
    Neurobiol Dis; 2006 Nov; 24(2):403-18. PubMed ID: 16963267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stress-induced hyperthermia paradigm as a physiological animal model for anxiety: a review of pharmacological and genetic studies in the mouse.
    Adriaan Bouwknecht J; Olivier B; Paylor RE
    Neurosci Biobehav Rev; 2007; 31(1):41-59. PubMed ID: 16618509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extending animal models of fear conditioning to humans.
    Delgado MR; Olsson A; Phelps EA
    Biol Psychol; 2006 Jul; 73(1):39-48. PubMed ID: 16472906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developments in treatment of anxiety disorders: psychotherapy, pharmacotherapy, and psychosurgery.
    Balon R
    Depress Anxiety; 2004; 19(2):63-76. PubMed ID: 15022141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1).
    Santarelli L; Gobbi G; Blier P; Hen R
    J Clin Psychiatry; 2002; 63 Suppl 11():11-7. PubMed ID: 12562138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fear, panic, anxiety, and disorders of emotion.
    Barlow DH; Chorpita BF; Turovsky J
    Nebr Symp Motiv; 1996; 43():251-328. PubMed ID: 8912311
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anxiety in neuroses and its relation to other symptoms].
    Týn Z
    Cesk Psychiatr; 1967 Apr; 63(2):98-109. PubMed ID: 6046894
    [No Abstract]   [Full Text] [Related]  

  • 11. Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress.
    Müller MB; Zimmermann S; Sillaber I; Hagemeyer TP; Deussing JM; Timpl P; Kormann MS; Droste SK; Kühn R; Reul JM; Holsboer F; Wurst W
    Nat Neurosci; 2003 Oct; 6(10):1100-7. PubMed ID: 12973355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal models of anxiety: are they suitable for predicting drug action in humans?
    Bourin M
    Pol J Pharmacol; 1997; 49(2-3):79-84. PubMed ID: 9437753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neurology of anxiety.
    Trimble MR
    Postgrad Med J; 1988; 64 Suppl 2():22-6. PubMed ID: 3064063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action in the treatment of anxiety.
    Shelton RC; Brown LL
    J Clin Psychiatry; 2001; 62 Suppl 12():10-5. PubMed ID: 11430613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research in anxiety disorders: from the bench to the bedside.
    Garner M; Möhler H; Stein DJ; Mueggler T; Baldwin DS
    Eur Neuropsychopharmacol; 2009 Jun; 19(6):381-90. PubMed ID: 19327970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The developmental origins of anxiety.
    Gross C; Hen R
    Nat Rev Neurosci; 2004 Jul; 5(7):545-52. PubMed ID: 15208696
    [No Abstract]   [Full Text] [Related]  

  • 17. Anxiety disorders and Parkinson's disease.
    Iruela LM; Ibañez-Rojo V; Palanca I; Caballero L
    Am J Psychiatry; 1992 May; 149(5):719-20. PubMed ID: 1575281
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of brain noradrenergic system and the hypothalamic-pituitary-adrenal (HPA) axis in man.
    Young EA; Abelson JL; Cameron OG
    Psychoneuroendocrinology; 2005 Sep; 30(8):807-14. PubMed ID: 15896919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety.
    Crespi F
    J Neurosci Methods; 2009 May; 180(1):97-105. PubMed ID: 19427535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of human psychopathology based on individual differences in novelty-seeking and anxiety.
    Pawlak CR; Ho YJ; Schwarting RK
    Neurosci Biobehav Rev; 2008 Oct; 32(8):1544-68. PubMed ID: 18619487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.